ILDONG PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15,180 KRW | -1.30% |
|
-0.85% | -16.41% |
| 22/05 | Dong-A ST to Become Second-Largest Shareholder of Idience in KRW25 Billion Deal | MT |
| 2023 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 31Cr | - | - | ||||
| 73TCr | ||||||
| 60TCr | ||||||
| 36TCr | ||||||
| 33TCr | ||||||
| 28TCr |
